Thalamic atrophy is associated with development of clinically definite multiple sclerosis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
PubMed
23613615
DOI
10.1148/radiol.13122424
PII: radiol.13122424
Knihovny.cz E-zdroje
- MeSH
- atrofie epidemiologie patologie MeSH
- dospělí MeSH
- hodnocení rizik MeSH
- kauzalita MeSH
- komorbidita MeSH
- lidé středního věku MeSH
- lidé MeSH
- magnetická rezonanční tomografie statistika a číselné údaje MeSH
- mladiství MeSH
- prevalence MeSH
- reprodukovatelnost výsledků MeSH
- roztroušená skleróza epidemiologie patologie MeSH
- senzitivita a specificita MeSH
- thalamus patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
PURPOSE: To investigate the association between the development of thalamic and cortical atrophy and the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). MATERIALS AND METHODS: This prospective study was approved by the institutional review board. Informed consent was given by 216 CIS patients, and patients were treated with 30 µg of intramuscular interferon β1a once a week. They were assessed with a magnetic resonance (MR) imaging examination at baseline, 6 months, 1 year, and 2 years. Patients were evaluated within 4 months of an initial demyelinating event, had two or more brain lesions on MR images, and had two or more oligoclonal bands in cerebrospinal fluid. MR imaging measures of progression included cumulative number and volume of contrast agent-enhanced (CE) new and enlarged T2 lesions, and changes in whole-brain, tissue-specific global, and regional gray matter volumes. Regression and mixed-effect model analyses were used. RESULTS: Over 2 years, 92 of 216 patients (42.6%) converted to CDMS; 122 (56.5%) CIS patients fulfilled McDonald 2005 criteria and 153 (70.8%) fulfilled McDonald 2010 criteria for MR imaging dissemination in time and space. The mean time to first relapse was 3.1 months, and mean annual relapse rate was 0.46. In mixed-effect model analysis, the lateral ventricle volume (P = .005), accumulation of CE (P = .007), new total T2 (P = .009) and new enlarging T2 lesions (P = .01) increase, and thalamic (P = .009) and whole-brain (P = .019) volume decrease were associated with development of CDMS. In multivariate regression analysis, decrease in thalamic volumes and increase in lateral ventricle volumes (P = .009) were MR imaging variables associated with the development of CDMS. CONCLUSION: Measurement of thalamic atrophy and increase in ventricular size in CIS is associated with CDMS development and should be used in addition to the assessment of new T2 and CE lesions.
Citace poskytuje Crossref.org
Time course of lesion-induced atrophy in multiple sclerosis
Monitoring of radiologic disease activity by serum neurofilaments in MS
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients
MRI correlates of disability progression in patients with CIS over 48 months
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome